|1.||Frémeaux-Bacchi, Véronique: 14 articles (11/2015 - 03/2004)|
|2.||Loirat, Chantal: 12 articles (05/2015 - 03/2004)|
|3.||Fremeaux-Bacchi, Veronique: 11 articles (09/2015 - 01/2008)|
|4.||Roumenina, Lubka T: 10 articles (02/2015 - 09/2009)|
|5.||Licht, Christoph: 9 articles (05/2015 - 02/2005)|
|6.||Sánchez-Corral, Pilar: 8 articles (10/2015 - 03/2007)|
|7.||Fakhouri, Fadi: 8 articles (02/2015 - 05/2010)|
|8.||Dragon-Durey, Marie-Agnès: 8 articles (01/2014 - 03/2004)|
|9.||Goodship, Timothy H J: 8 articles (01/2011 - 10/2004)|
|10.||Remuzzi, Giuseppe: 7 articles (12/2015 - 03/2007)|
|1.||Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
05/15/2015 - "Based on genetic studies, FH-related protein 5 (CFHR5) is implicated in glomerular diseases, such as atypical hemolytic uremic syndrome, dense deposit disease, and CFHR5 nephropathy. "
08/01/2015 - "Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015."
08/01/2013 - "Atypical hemolytic uremic syndrome (aHUS) associated with membranoproliferative glomerulonephritis (MPGN) is an uncommon clinical presentation, especially in children. "
08/01/2013 - "Atypical hemolytic uremic syndrome with membranoproliferative glomerulonephritis."
10/01/2012 - "We report the case of a boy with a novel CFH gene mutation who presented with a membranoproliferative (MPGN) pattern of glomerular injury and developed 2 years later atypical hemolytic uremic syndrome (aHUS); this description shows that CFH alteration leads to two different renal diseases in the same patient. "
10/01/2015 - "Pregnancy-associated atypical hemolytic uremic syndrome is a systemic disease associated with high morbidity and mortality rates, caused by dysregulation of the alternative complement pathway, leading to uncontrolled complement activation resulting in thrombotic microangiopathy. "
09/01/2015 - "Thrombotic microangiopathy after allogeneic HSCT shares similarities with atypical hemolytic uremic syndrome (aHUS) in the underlying pathomechanisms. "
06/01/2015 - "Atypical hemolytic uremic syndrome is a rare thrombotic microangiopathy caused by chronic defective regulation of the complement activation. "
06/01/2015 - "Thrombotic microangiopathies (TMA) such as atypical hemolytic uremic syndrome (aHUS) have evolved from rare, fulminant childhood afflictions to uncommon diseases with acute and chronic phases involving both children and adults. "
06/01/2015 - "Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome."
|3.||Thrombotic Thrombocytopenic Purpura
11/01/2015 - "The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring."
06/01/2013 - "Thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: an update."
03/01/2013 - "Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome."
05/01/2010 - "In contrast to pregnancy-associated thrombotic thrombocytopenic purpura, the pathogenesis and presentation of pregnancy-associated atypical hemolytic uremic syndrome (P-aHUS) remain ill-defined. "
09/01/2013 - "Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: clinically differentiating the thrombotic microangiopathies."
|4.||Macular Degeneration (Age-Related Maculopathy)
01/01/2014 - "Novel links between CFHRs and various diseases (C3 glomerulopathies, atypical hemolytic uremic syndrome and age-related macular degeneration) have been revealed in recent years, but we are still far from understanding their biological function. "
03/01/2013 - "Mutations/polymorphisms within these glycosaminoglycan-binding sites have been associated with age-related macular degeneration (AMD) and atypical hemolytic uremic syndrome. "
01/08/2010 - "The SCR-16/20 site is novel and indicates the importance of the FH-CRP interaction for both age-related macular degeneration and atypical hemolytic uremic syndrome."
06/01/2008 - "Further evidence of the importance of the alternative pathway has been provided by studies of human diseases, where mutations or dysfunctional polymorphisms that promote activation of this pathway are highly associated with the diseases atypical hemolytic uremic syndrome, dense deposit disease, and age-related macular degeneration. "
01/01/2012 - "CFH I890 and L1007 are two genetic variations repeatedly associated with atypical hemolytic uremic syndrome and also found in patients with dense deposit disease and age-related macular degeneration. "
|5.||Chronic Kidney Failure (Chronic Renal Failure)
12/01/2015 - "Of the 63 remaining patients, 6 had prolonged or relapses of renal function disturbances, but only one patient with atypical Hemolytic Uremic Syndrome developed end-stage renal failure. "
06/01/2014 - "Atypical hemolytic uremic syndrome (aHUS) is a life-threatening multisystemic condition often leading to end-stage renal failure. "
03/01/2014 - "Atypical hemolytic uremic syndrome (aHUS) evolves into end-stage renal failure in nearly half of affected patients and is associated with defective regulation of the alternative complement pathway. "
04/01/2011 - "A 15-year-old male patient developed atypical hemolytic uremic syndrome (aHUS) at 16 months of age leading to end-stage renal disease. "
07/01/2009 - "Atypical hemolytic uremic syndrome remains a challenge to diagnose and treat, with significant acute morbidity and risk for progression to end stage renal disease. "
|2.||Complement System Proteins (Complement)
|3.||thymidine 5'-triphosphate (TTP)
|5.||Complement C5 (Complement 5)
|6.||Complement Factor H (Factor H)
|7.||Microangiopathic hemolytic anemia
|9.||Proteins (Proteins, Gene)
|10.||Shiga Toxin (Shigella Toxin)
|3.||Transplantation (Transplant Recipients)
|5.||Homologous Transplantation (Allograft)